{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:36:15Z","timestamp":1790883375563,"version":"4.1.0"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,5,15]]},"DOI":"10.2169\/internalmedicine.8815-21","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T22:10:05Z","timestamp":1647036605000},"page":"1609-1612","source":"Crossref","is-referenced-by-count":12,"title":["Acute Meningoencephalitis after COVID-19 Vaccination in an Adult Patient with Rheumatoid Vasculitis"],"prefix":"10.2169","volume":"61","author":[{"given":"Joe","family":"Senda","sequence":"first","affiliation":[{"name":"Department of Neurology and Rehabilitation, Komaki City Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosei","family":"Ashida","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Komaki City Hospital, Japan"},{"name":"Department of Endocrinology and Diabetes, Tokai Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Komaki City Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Komaki City Hospital, Japan"},{"name":"Department of Cardiology, Komaki City Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Polack FP, Thomas SJ, Kitchin N, et al.; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 383: 2603-2615, 2020.","DOI":"10.1056\/NEJMoa2034577"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Baden LR, El Sahly HM, Essink B, et al.; COVE Study Group. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384: 403-416, 2020.","DOI":"10.1056\/NEJMoa2035389"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. McMurry R, Lenehan P, Awasthi S, et al. Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines. Med (N Y) 2: 1-14, 2021.","DOI":"10.1101\/2021.02.20.21252134"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation 144: 471-484, 2021.","DOI":"10.1161\/CIRCULATIONAHA.121.056135"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vidula MK, Ambrose M, Glassberg H, et al. Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus 13: e15576, 2021.","DOI":"10.7759\/cureus.15576"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ahmad SA, Salih BK, Hama Hussein KF, Mikael TM, Kakamad FH, Salih AM. Aseptic meningoencephalitis after COVID-19 vaccination: a case report. Ann Med Surg (Lond) 71: 103028, 2021.","DOI":"10.1016\/j.amsu.2021.103028"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Saito K, Shimizu T, Suzuki-Inoue K, Ishida T, Wada Y. Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine. Neurol Sci 42: 4433-4435, 2021.","DOI":"10.1007\/s10072-021-05543-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Reis Carneiro D, Matos A, Morgadinho A. Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine. Rev Neurol (Paris) 178: 160-161, 2021.","DOI":"10.1016\/j.neurol.2021.10.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chan AC, Tan BY, Goh Y, Tan SS, Tambyah PA. Aseptic meningitis after BNT-162b2 COVID-19 vaccination. Brain Behav Immun Health 19: 100406, 2022.","DOI":"10.1016\/j.bbih.2021.100406"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chen CJ, Hsieh LL, Lin SK, et al. Optimization of the CDC protocol of molecular diagnosis of COVID-19 for timely diagnosis. Diagnostics (Basel) 10: 333-338, 2020.","DOI":"10.3390\/diagnostics10050333"},{"key":"11","unstructured":"11. Venkatesan A, Tunkel AR, Bloch KC, et al.; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 57: 1114-1128, 2013."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rodriguez Alvarez M, Rodr\u00edguez Valencia LM, Seidman R, et al. Rheumatoid meningitis and infection in absence of rheumatoid arthritis history: review of 31 cases. Clin Rheumatol 39: 3833-3845, 2020.","DOI":"10.1007\/s10067-020-05221-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Inoue C, Hagiya H, Nishimura Y, Sui O. Rheumatoid meningoencephalitis. Intern Med 59: 3255-3256, 2020.","DOI":"10.2169\/internalmedicine.5374-20"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Higashida-Konishi M, Izumi K, Tsukamoto M, et al. Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement. Clin Rheumatol 39: 2441-2448, 2020.","DOI":"10.1007\/s10067-020-05044-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mondal R, Ganguly U, Deb S, et al. Meningoencephalitis associated with COVID-19: a systematic review. J Neurovirol 27: 12-25, 2021.","DOI":"10.1007\/s13365-020-00923-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lv P, Peng F, Zhang Y, et al. COVID-19-associated meningoencephalitis: a care report and literature review. Exp Ther Med 21: 362-368, 2021.","DOI":"10.3892\/etm.2021.9793"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lamb YN. BNT162b2 mRNA COVID-19 vaccine: first approval. Drugs 8: 495-501, 2021.","DOI":"10.1007\/s40265-021-01480-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lubomski M, Sy J, Buckland M, et al. Rheumatoid leptomeningitis presenting with an acute neuropsychiatric disorder. Pract Neurol 19: 68-71, 2019.","DOI":"10.1136\/practneurol-2018-001978"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lattanzi S, Cagnetti C, Di Bella P, et al. Leptomeningeal inflammation in rheumatoid arthritis. Neurol Neuroimmunol Neuroinflamm 1: e43, 2021.","DOI":"10.1212\/NXI.0000000000000043"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 15: 89-102, 2019.","DOI":"10.1038\/s41582-018-0112-x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/10\/61_8815-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:13:01Z","timestamp":1715231581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/10\/61_8815-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,15]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8815-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,15]]},"article-number":"8815-21"}}